Skip to main content
. 2022 Aug 3;12:13361. doi: 10.1038/s41598-022-17579-0

Figure 7.

Figure 7

miR-101a over-expression does not alter bone mass in female mice. R26 control, miR-101 control, and miR-101a over-expressing (R26/101) female mice were treated with doxycycline from inception to sacrifice (8 weeks). The figure depicts body weight (A), femur length (B), trabecular bone parameters (C–G), and cortical thickness (H) as assessed by µCT (n = 9 to 10, mean ± STD). *p < 0.05 and **p < 0.01.